Thank you for Subscribing to Healthcare Business Review Weekly Brief
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and high-definition solutions to improve patient outcomes and reduce procedural costs.
FREMONT CA: NeuroOne Medical Technologies Corporation, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that it has executed an agreement with RBC Medical Innovations to develop and manufacture a proprietary radiofrequency (RF) generator for use with NeuroOne's combination recording and ablation electrode that is being designed to both record brain activity and ablate brain tissue using the same electrode.
Dave Rosa, President, and CEO of NeuroOne Medical Technologies Corporation, says, "RBC is a well-respected firm with over 25 years of design, development and manufacturing of differentiated medical devices with some of the world's largest and most innovative companies. We believe this partnership will allow NeuroOne to offer a proprietary complete system combining our game-changing combination ablation electrode with the hardware and software required to perform these procedures.
This will allow us to fully participate in a market estimated in excess of $100M worldwide and growing. The project is expected to be completed in late 2022, pending receipt of regulatory clearance."
Currently, two separate hospital visits and surgeries are required to treat patients that have seizures due to epilepsy or brain tumors that contribute to seizures. Combining the diagnostic and therapeutic functions is expected to save time, money and potentially improve patient outcomes, given the patient will be able to get both procedures performed with the same device and as part of the same procedure requiring one hospital visit. If successful, this will represent the Company's first therapeutic product offering.
Carl Mayer, President, and CEO of RBC Medical Innovations, says, "We are honored to partner with NeuroOne on this innovative new system that will significantly improve patient care. Using the cutting-edge Advantage Platforms™, RBC will reduce time-to-market, increase reliability and ultimately contribute to NeuroOne's ongoing success."